Search

Filters

Use filters to refine the search results.

Now showing items 1-1 of 1

Development of a novel fluorine-18 labeled deuterated fluororasagiline ([ 18 F]fluororasagiline-D 2 ) radioligand for PET studies of monoamino oxidase B (MAO-B)

Nag, S. Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, S-17176 Stockholm, Sweden sangram.nag@ki.se; Kettschau, G. Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Lehmann, L. Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Toth, M. Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, S-17176 Stockholm, Sweden; Thiele, A. Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany; Varrone, A. Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, S-17176 Stockholm, Sweden; Halldin, C. Karolinska Institutet, Department of Clinical Neuroscience, Psychiatry Section, S-17176 Stockholm, Sweden; Heinrich, T. Bayer HealthCare AG, Global Drug Discovery, Berlin, Germany (2015-01-22)

Now showing items 1-1 of 1